Does statin therapy interfere with the ability of claudicant patients to exercise? [1]

Vascular and Endovascular Surgery

Volumn 41, Issue 5, 2007, Pages 473-

  Mascitelli, Luca ^a   Pezzetta, Francesca ^b  

^a Sanitary Service   (Italy)

^b Ospedale di San Vito al Tagliamento   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CLAUDICATION; EXERCISE; HUMAN; LETTER; MUSCLE DISEASE; MYALGIA; PERIPHERAL VASCULAR DISEASE; WALKING;

EXERCISE THERAPY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERMITTENT CLAUDICATION; MUSCULAR DISEASES; PAIN; QUALITY OF LIFE; TREATMENT OUTCOME; WALKING;

EID: 35348824190     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/1538574407307407     Document Type: Letter

References (4)

1. Serracino-Inglott F., Owen G., Carter A., Dix F., Smyth JV, Mohan IV All patients benefit equally from a supervised exercise program for claudication. Vasc Endovascular Surg. 2007 ; 41: 212-216.
2. Thompson PD, Clarkson P., Karas RH Statin-associated myopathy. JAMA. 2003 ; 289: 1681-1690.
3. Bruckert E., Hayem G., Dejager S., Yau C., Begaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients: The PRIMO Study. Cardiovasc Drugs Ther. 2005 ; 19: 403-414.
4. Sinzinger H., O'Grady J. Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscolar problems. Br J Clin Pharmacol. 2004 ; 57: 525-528.